Procyrion, Inc.

About Procyrion, Inc.

Procyrion is a medical technology company focused on addressing the unmet clinical needs of heart failure patients through the development of innovative percutaneous mechanical circulatory support (pMCS) devices. Their mission is to improve patient outcomes by tackling conditions like cardiorenal syndrome.

Products & Services

Aortix™:A percutaneous mechanical circulatory support (pMCS) device designed to treat heart failure patients who are too sick for medication alone. It aims to reduce cardiac workload, increase renal perfusion, and disrupt the cardiorenal syndrome cycle. Currently in research and development phase, not available for sale.

Specialties

Percutaneous Mechanical Circulatory Support (pMCS) Heart Failure Treatment Cardiorenal Syndrome Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series E T: - FT: Series E	A: 57700000 MR: - FA: 57.7 million FAN: 57700000	D: 2024-02-05 FD: 2024-02-05	3 investors

Series E Latest

2024-02-05

$57.7M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Eric S. Fain

President & CEO

LinkedIn (Pro only)

R

Reynolds M. Delgado III

Founder & Chief Medical Officer

J

Jason Heuring

Chief Scientific Officer

LinkedIn (Pro only)

E

Elisabeth (Beth) Neely

Senior Vice President, Clinical And Regulatory Affairs

A

Av Edidin

Senior Vice President, Development and Manufacturing

K

Katherine Cox

Vice President, Quality Assurance

View 19 more team members with Pro

Unlock Full Team Directory

Recent News

Procyrion, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised